Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Forward ScienceROCO:7530 +6.06%39 PS Ratio is 8.86 as of Jul. 22, 2026, which is 112% above its 10-year median of 4.18. GuruFocus rates ROCO:7530 with a GF Score™ of 39/100 and a GF Value™ of NT$14.11 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 3,021 Industrial Products companies, Forward Science ranks worse than 90.27% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Forward Science's share price is NT$37.55.
Forward Science's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4.24. Hence, Forward Science's PS Ratio for today is 8.86.
The historical rank and industry rank for Forward Science's PS Ratio or its related term are showing as below:
ROCO:7530'
s PS Ratio Range Over the Past 10 Years
Min: 1.87 Med: 4.18 Max: 11.64
Current: 8.89
During the past 8 years, Forward Science's highest PS Ratio was 11.64. The lowest was 1.87. And the median was 4.18.
ROCO:7530's PS Ratio is ranked worse than 90.27% of 3021
companies
in the Industrial Products industry
Industry Median: 1.9
vs ROCO:7530: 8.89
Forward Science Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Forward Science was -31.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -14.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -10.70% per year.
During the past 8 years, Forward Science's highest 3-Year average Revenue per Share Growth Rate was 3.50% per year. The lowest was -21.30% per year. And the median was -11.30% per year.
Back to Basics: PS Ratio
Forward Science (ROCO:7530) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Forward Science PS Ratio Related Terms
Forward Science PS Ratio Historical Data
* Premium members only.
The historical data trend for Forward Science's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Forward Science's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forward Science PS Ratio vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Forward Science's PS Ratio distribution charts can be found below:
* The bar in red indicates where Forward Science's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Forward Science's Share Price of today is NT$37.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Forward Science's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4.24.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Forward Science (ROCO:7530) has a PS Ratio of 8.86 as of Jul. 22, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Forward Science and its competitors. This is 112% above median its historical median of 4.18. Over the past decade, Forward Science's PS Ratio has ranged from 1.87 to 11.64. According to the industry distribution chart, Forward Science ranks #2727 out of 3021 companies in the Industrial Products industry, placing it in the top 90.3%.
Is Forward Science's PS Ratio too high?
Forward Science's current PS Ratio of 8.86 is 112% above median its 10-year median of 4.18. Over the past 10 years, this metric has ranged from a low of 1.87 to a high of 11.64. The Industrial Products industry median PS Ratio is 1.90. Forward Science's value of 8.86 is 366.3% above this industry median. Based on the distribution chart, Forward Science ranks #2727 out of 3021 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Forward Science has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Forward Science's PS Ratio compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Forward Science ranks #2727 out of 3021 companies for PS Ratio. This places Forward Science in the lower half of its industry. The industry median PS Ratio is 1.90. Forward Science's value of 8.86 is 366.3% above this benchmark. Historically, Forward Science's own PS Ratio has ranged from 1.87 to 11.64 over the past decade. While the company's 10-year median is 4.18 vs. the industry median of 1.90, Forward Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for an Industrial Products company?
The median PS Ratio among Industrial Products companies is 1.90, based on 3,021 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Forward Science's current PS Ratio of 8.86 is 366.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Forward Science and its competitors. For the Industrial Products industry, the median PS Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forward Science's current PS Ratio is 8.86, which is 112% above median its own 10-year median of 4.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forward Science stock overvalued right now?
Based on GuruFocus' analysis, Forward Science (ROCO:7530) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$14.11, compared to a current price of NT$37.55 — trading 166.1% above its estimated fair value. The current PS Ratio is 8.86, which is 112% above median its 10-year median of 4.18 and 366.3% above the Industrial Products industry median of 1.90. Forward Science's overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Forward Science (ROCO:7530), the current PS Ratio is 8.86 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Forward Science (ROCO:7530) Overvalued in 2026?
Based on GuruFocus' analysis, Forward Science stock appears to be overvalued.
The current stock price of NT$37.55 is trading 166.1% above its estimated GF Value™ of NT$14.11.
GuruFocus considers Forward Science to be Significantly Overvalued.
Key valuation signals for ROCO:7530:
PS Ratio: 8.86 (112% above median its 10-year median of 4.18)
GF Value™: NT$14.11 vs. price of NT$37.55 (166.1% above fair value)
Industry Position: 366.3% above the Industrial Products median (#2727 of 3021)
No single metric tells the full story. See the ROCO:7530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Forward Science Corp is engaged in the manufacturing and maintenance of vacuum pumps. It is also involved in precision parts manufacturing that includes Stainless Processing, Aluminum Processing, Casting Processing, and Metal Finishing among others. Geographically, the company generates the majority of its revenue from Taiwan.
39GF Score
Get the complete analysis for ROCO:7530
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7530 has been successfully added to your 
